The Different Analgesic Potency of Volatile Anesthetics at Equi-MAC
Study Details
Study Description
Brief Summary
The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 3 |
Detailed Description
Volatile anesthetics vary in their relative hypnotic potencies. Recent studies demonstrated that equi-minimum alveolar concentration of various volatile anesthetics produced different EEG-derived indices such as bispectral index. However, there was no controlled study that demonstrates the difference of analgesic potency. The aim of this clinical trial is to evaluate the difference of analgesic potency of sevoflurane and desflurane at equi-minimum alveolar concentration using a surgical pleth index.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Sevoflurane Anesthesia was maintained with sevoflurane. |
Drug: Sevoflurane
Anesthesia was maintained with sevoflurane in patients undergoing arthroscopic shoulder surgery under general anesthesia and interscalene brachial plexus block.
Other Names:
|
Experimental: Desflurane Anesthesia was maintained with desflurane. |
Drug: Desflurane
Anesthesia was maintained with desflurane in patients undergoing arthroscopic shoulder surgery under general anesthesia and interscalene brachial plexus block.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Analgesic potency of volatile anesthetics [the first 60 min of maintaining a steady state 1 MAC of volatile agents]
The analgesic potency was evaluated by surgical pleth index value
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients undergoing arthroscopic shoulder surgery
-
patients with american society of anesthesiologist physical status I, II
-
patients aged 19-65 years
-
patients obtaining written informed consent
Exclusion Criteria:
-
patients with a history of any psychiatric or neurological disease
-
patients who had received any medication affecting the central nervous system
-
patients who had received medication affecting the sympathetic or parasympathetic nervous systems
-
patients who have not received interscalene approach brachial plexus block (refusal or failure)
-
pregnant women
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kangbuk Samsung Hospital | Seoul | Korea, Republic of | 03181 |
Sponsors and Collaborators
- Kangbuk Samsung Hospital
Investigators
- Principal Investigator: Kyoungho Ryu, M.D., Kangbuk Samsung Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2015-09-028